Axel Perlwitz

Axel G Perlwitz is currently the Chief Regulatory Affairs Officer at Transpire Bio. With a background in Chemistry, Axel has held various senior positions in regulatory affairs within the pharmaceutical industry, including at Lupin Inhalation Research Center, Glenmark Pharmaceuticals, Teva Branded Pharmaceutical Products R&D Inc., and Cardinal Health / Catalent Pharma Solutions. Axel's experience spans over two decades, with expertise in respiratory drug products and inhalation technologies.